Overview
Description
Irhythm Technologies Inc. is a healthcare technology company that specializes in the development of remote monitoring solutions for cardiac arrhythmias. Its primary product, the Zio service, is a comprehensive platform integrating wearable biosensors and cloud-based data analytics to facilitate the early detection and diagnosis of irregular heart rhythms. By harnessing advanced biosensing technology, Irhythm provides continuous, real-time heart monitoring, enabling healthcare providers to make more informed decisions about patient care.
The company operates at the critical intersection of healthcare and technology, playing an influential role in the medical devices sector through its innovative approach to cardiac monitoring. By improving the accuracy and efficiency of arrhythmia detection, Irhythm Technologies Inc. contributes significantly to enhanced clinical outcomes and helps reduce the burdens on healthcare systems.
Launched with a mission to elevate cardiovascular care, Irhythm Technologies has gained market significance by addressing the unmet needs of both patients and healthcare providers. The company's solutions are pivotal in transitioning cardiac care from traditional clinical settings to personalized home environments, thereby expanding the accessibility and effectiveness of cardiac health management.
About
CEO
Mr. Quentin S. Blackford
Employees
2000
Address
699 8th Street
Suite 600
San Francisco, 94103, CA
United States
Suite 600
San Francisco, 94103, CA
United States
Phone
415 632 5700
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Medical Devices
Country
United States
MIC code
XNGS